Borrelia Evaluatoin

Article View: bionet.diagnostics

Article #1424

Back to bionet.diagnostics Previous Next

#1424

From: Bryan Kiehl
Date: Wed, 07 Jun 1995 00:00

17 lines
982 bytes

We have finished a controlled field evaluation of a new Lyme disease serology 
product and would like to "beta" test it in several US sites. These kits will 
not be sold into the US until FDA cleared. Sites must have reasonable access 
to patient history and use serology test methods that include a western blot 
analysis using criteria similar to those described by Dressler.

If interested, please contact me at b3748@cts.com or by FAX at 619-592-9400.

Thanks,
Bryan Kiehl

Bryan Kiehl
GenBio
15222-A Avenue of Science
San Diego, CA 92128
(619) 592-9300, ext 309
(619) 592-9400 [FAX]

Technical Details

Message-ID: <3r2uaq$97s_003@kiehl.cts.com>

Path: arc1-ca.pugleaf.net!unknown!not-for-mail

Show Full Headers

Complete Article Headers

X-Google-Language: ENGLISH,ASCII-7-bit
X-Google-Thread: 10eaff,a9a4bf7ef6a83800,start
X-Google-Attributes: gid10eaff,public
From: b3748@cts.com (Bryan Kiehl)
Subject: Borrelia Evaluatoin
Date: 1995/06/07
Message-ID: <3r2uaq$97s_003@kiehl.cts.com>
X-Deja-AN: 103958535
sender: news@crash.cts.com (news subsystem)
organization: CTSNET
newsgroups: bionet.diagnostics